Africa Pharmaceutical Regulatory Affairs Market To Reach $213.06 Million By 2030

Africa Pharmaceutical Regulatory Affairs Market Growth & Trends

The Africa pharmaceutical regulatory affairs market size is expected to reach USD 213.06 million by 2030, registering a CAGR of 6.81% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is driven by increasing demand for pharmaceutical products across the Africa region coupled with the growing need for safe and effective drugs, which requires stringent regulatory oversight.Moreover, the rise in the prevalence of various diseases, including communicable and non-communicable diseases, propels the demand for pharmaceuticals.

The COVID-19 pandemic had a significant impact on the market. The pandemic highlighted the importance of a robust regulatory framework to expedite the approval process for important drugs and vaccines, and African regulatory authorities responded by streamlining emergency authorization procedures. Moreover, COVID-19 emphasized the importance of strengthening pharmaceutical manufacturing capabilities within the region. Several countries have reduced their dependence on imports and are now investing in local production to enhance supply chain resilience. These factors have contributed to market growth.

The increasing number of clinical trials conducted in Africa is impacting the regulatory landscape. Many global pharmaceutical companies are conducting trials in the region due to the diverse patient populations and lower costs. As a result, stringent regulatory oversight is essential to safeguarding trial participants and ensuring the validity of research outcomes, bolstering the role of regulatory affairs. Moreover, the ongoing efforts to improve healthcare access and infrastructure in Africa are driving the demand for pharmaceutical products. As healthcare systems continue to evolve, regulatory affairs play an important role in assuring the quality and efficacy of medicines, thus driving the market growth.

 Request a free sample copy or view report summary: Africa Pharmaceutical Regulatory Affairs Market Report

Africa Pharmaceutical Regulatory Affairs Market Report Highlights

• By services, the regulatory writing & publishing segment dominated the market with a share of over 36% in 2022. The legal representation segment is projected to witness the fastest growth rate in the coming years

• By category, the drugs segment dominated the market in 2022. Regulatory affairs play a very important role in the entire drug development, manufacturing, and commercialization continuum

• By indication, the oncology segment held the highest share of the market in 2022. This can be attributed to the high prevalence of cancer, which is boosting the need for safe and effective treatment options

• By product stage, the clinical studies segment held the highest share of the market in 2022. This can be attributed to the increasing number of clinical trial registrations over the past few years

• By service provider, the outsourcing segment dominated the market in 2022. This can be attributed to the increasing popularity of these services as outsourcing enables healthcare companies to reduce costs and prioritize strategic projects

• By company size, the medium segment dominated the market in 2022. These companies have a broader product portfolio and a wider geographic presence, allowing them to serve a larger customer base across different African countries

Africa Pharmaceutical Regulatory Affairs Market Segmentation

Grand View Research has segmented the Africa pharmaceutical regulatory affairs market based on services, category, indication, product stage, service provider, company size, and country:

Africa Pharmaceutical Regulatory Affairs Services Outlook (Revenue, USD Million, 2018 - 2030)

• Regulatory Consulting

• Legal Representation

• Regulatory Writing & Publishing

• Writing

• Publishing

• Product Registration & Clinical Trial Applications

• Other Services

Africa Pharmaceutical Regulatory Affairs Category Outlook (Revenue, USD Million, 2018 - 2030)

• Drugs

• Innovator

• Preclinical

• Clinical

• Pre-Market Approval (PMA)

• Generics

• Preclinical

• Clinical

• Pre-Market Approval (PMA)

• Biologics

• Biotech

• Preclinical

• Clinical

• Pre-Market Approval (PMA)

• ATMP

• Preclinical

• Clinical

• Pre-Market Approval (PMA)

• Biosimilars

• Preclinical

• Clinical

• Pre-Market Approval (PMA)

Africa Pharmaceutical Regulatory Affairs Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology

• Neurology

• Cardiology

• Immunology

• Others

Africa Pharmaceutical Regulatory Affairs Product Stage Outlook (Revenue, USD Million, 2018 - 2030)

• Preclinical

• Clinical studies

• PMA

Africa Pharmaceutical Regulatory Affairs Service Provider Outlook (Revenue, USD Million, 2018 - 2030)

• In-house

• Outsourcing

Africa Pharmaceutical Regulatory Affairs Company Size Outlook (Revenue, USD Million, 2018 - 2030)

• Small

• Medium

• Large

Africa Pharmaceutical Regulatory Affairs Country Outlook (Revenue, USD Million, 2018 - 2030)

• Africa

  • South Africa

  • Botswana

  • Namibia

  • Zimbabwe

  • Algeria

  • Zambia

  • Tanzania

  • Rwanda

  • Ghana

  • Nigeria

  • Uganda

  • Mauritius

  • Kenya

  • Rest of Africa

List of Key Players in the Africa Pharmaceutical Regulatory Affairs Market

• Freyr

• IQVIA Inc

• ICON plc

• WuXi AppTec

• Charles River Laboratories

• Labcorp Drug Development

• Parexel International Corporation

• Pharmalex GmbH

• Pharmexon

• Genpact